Multiple valve disease-Assessment, strategy and intervention

EuroIntervention

Volumn 11, Issue , 2015, Pages W14-W16

  Vahanian, Alec ^a   Himbert, Dominique ^a   Brochet, Eric ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Aortic stenosis; Mitral regurgitation; Surgical valve replacement; Transcatheter aortic valve implantation; Transcatheter mitral valve repair; Tricuspid regurgitation

Indexed keywords

AORTA STENOSIS; ATRIAL FIBRILLATION; CARDIOVASCULAR EQUIPMENT; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HIGH RISK PATIENT; HOSPITAL READMISSION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INCIDENCE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; MITRAL VALVE STENOSIS; MITRAL VALVE SURGERY; MORBIDITY; MULTIPLE VALVE DISEASE; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS MITRAL COMMISSUROTOMY; PRACTICE GUIDELINE; PULMONARY HYPERTENSION; REVIEW; RHEUMATIC HEART DISEASE; SYMPTOMATOLOGY; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT INDICATION; TRICUSPID VALVE REGURGITATION; VALVULAR HEART DISEASE; ADVERSE EFFECTS; ANNULOPLASTY; CONVALESCENCE; DEVICES; HEART CATHETERIZATION; HEART VALVE; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HEMODYNAMICS; PATHOPHYSIOLOGY; PATIENT SELECTION; PREDICTIVE VALUE; PROCEDURES; PROSTHESIS DESIGN; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

CARDIAC CATHETERIZATION; CARDIAC VALVE ANNULOPLASTY; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEART VALVES; HEMODYNAMICS; HUMANS; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROSTHESIS DESIGN; RECOVERY OF FUNCTION; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 84943193773     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV11SWA3     Document Type: Review

References (7)

1. Unger P, Rosenhek R, Dedobbeleer C, Berrebi A, Lancellotti P. Management of multiple valve disease. Heart. 2011;97:272-7.
2. Iung B, Baron G, Tornos P, Gohlke-Bärwolf C, Butchart EG, Vahanian A. Valvular heart disease in the community: a European experience. Curr Probl Cardiol. 2007;32:609-61.
3. Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS), Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Iung B, Lancellotti P, Pierard L, Price S, Schäfers HJ, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala M. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012;33:2451-96.
4. Bax JJ, Delgado V, Bapat V, Baumgartner H, Collet JP, Erbel R, Hamm C, Kappetein AP, Leipsic J, Leon MB, MacCarthy P, Piazza N, Pibarot P, Roberts WC, Rodés-Cabau J, Serruys PW, Thomas M, Vahanian A, Webb J, Zamorano JL, Windecker S. Open issues in transcatheter aortic valve implantation. Part 1: patient selection and treatment strategy for transcatheter aortic valve implantation. Eur Heart J. 2014;35: 2627-38.
5. Rudolph V, Schirmer J, Franzen O, Schlüter M, Seiffert M, Treede H, Reichenspurner H, Blankenberg S, Baldus S. Bivalvular transcatheter treatment of high-surgical-risk patients with coexisting severe aortic stenosis and significant mitral regurgitation. Int J Cardiol. 2013;167:716-20.
6. Himbert D, Bouleti C, Iung B, Nejjari M, Brochet E, Depoix JP, Ghodbane W, Fassa AA, Nataf P, Vahanian A. Transcatheter valve replacement in patients with severe mitral valve disease and annular calcification. J Am Coll Cardiol. 2014;64:2557-8.
7. Ohno Y, Attizzani GF, Capodanno D, Cannata S, Dipasqua F, Immé S, Barbanti M, Ministeri M, Caggegi A, Pistritto AM, Chiarandà M, Ronsivalle G, Giaquinta S, Farruggio S, Mangiafico S, Scandura S, Tamburino C, Capranzano P, Grasso C. Association of tricuspid regurgitation with clinical and echocardiographic outcomes after percutaneous mitral valve repair with the MitraClip System: 30-day and 12-month follow-up from the GRASP Registry. Eur Heart J Cardiovasc Imaging. 2014;15:1246-55.